세계의 아스파르트산 시장 예측(-2032년) : 제품 유형, 제조 방법, 순도 등급, 용도별, 지역별 분석

According to Stratistics MRC, the Global Aspartic Acid Market is accounted for $127.25 million in 2025 and is expected to reach $228.18 million by 2032 growing at a CAGR of 8.7% during the forecast period. Aspartic acid is a naturally occurring, non-essential amino acid vital for protein formation and nervous system health. It participates in the urea cycle, aiding in nitrogen removal, and acts as a building block for other amino acids and important biomolecules. Additionally, it plays a role in energy generation through the citric acid cycle. Present in many dietary sources, aspartic acid is essential for supporting metabolic processes, efficient neurotransmission, and proper cellular activities throughout the human body.

According to the International Federation of Organic Agriculture Movements (IFOAM), in 2023, Australia led global organic farming with 53 million hectares of organic agricultural land. India followed with 4.48 million hectares and Argentina with 4.05 million hectares.

Market Dynamics:

Driver:

Rising demand for low-calorie sweeteners

As obesity and diabetes rates climb globally, food and beverage manufacturers are reformulating products to reduce sugar content. Aspartic acid's ability to deliver sweetness without caloric load makes it attractive for diet sodas, sugar-free gums, and nutritional supplements. Regulatory support for sugar reduction initiatives is further accelerating adoption across developed and emerging markets. Innovations in flavor masking and stability enhancement are expanding its usability in complex formulations. The rise of personalized nutrition and functional foods is also boosting interest in amino acid-based sweeteners. Overall, aspartic acid is becoming integral to the clean-label and wellness-driven product landscape.

Restraint:

Competition from alternative sweeteners and amino acids

Despite its utility, aspartic acid faces stiff competition from other sweeteners like stevia, sucralose, and monk fruit extracts, which are gaining traction due to natural origin and broader consumer acceptance. Additionally, amino acids such as glutamic acid and phenylalanine are being explored for similar applications, creating overlap in functional roles. Market players must navigate evolving consumer preferences that increasingly favor plant-based and organic ingredients. Regulatory scrutiny around synthetic additives is also influencing purchasing decisions, especially in premium segments. The influx of biotech-derived sweeteners is reshaping the competitive landscape. As differentiation narrows, maintaining market share requires innovation in formulation and positioning.

Opportunity:

Increasing applications in anti-aging and cosmetic products

Aspartic acid is gaining momentum in the personal care industry due to its role in skin hydration, collagen synthesis, and cellular regeneration. Its inclusion in anti-aging serums, moisturizers, and hair care products is rising, driven by consumer demand for amino acid-enriched formulations. The compound's ability to support protein metabolism and skin elasticity makes it valuable in dermocosmetic applications. Emerging research linking amino acids to skin barrier repair is expanding its relevance in sensitive skin and therapeutic skincare lines. Premium brands are leveraging its multifunctionality to enhance product claims and differentiate offerings. This diversification into cosmetics opens new revenue streams beyond food and pharma.

Threat:

High capital investment for manufacturing

The need for sterile environments, advanced reactors, and quality control systems adds to operational complexity. Smaller firms often struggle to meet GMP and ISO standards, limiting their ability to scale. Volatility in raw material prices and energy costs further impacts profitability. Regulatory compliance across multiple jurisdictions increases documentation and audit burdens. As demand grows, capacity expansion becomes critical but capital constraints may hinder timely response.

Covid-19 Impact:

Lockdowns and transport restrictions led to inventory shortages across food, pharma, and cosmetic sectors. However, the crisis also heightened awareness of health and immunity, boosting demand for amino acid-based supplements. Manufacturers adapted by decentralizing operations and investing in digital monitoring systems to ensure continuity. Regulatory bodies introduced fast-track approvals for nutritional products, accelerating market entry for immune-support formulations. E-commerce channels became vital for distribution, reshaping consumer access and engagement. Post-pandemic strategies now emphasize resilience, automation, and diversified sourcing in the aspartic acid value chain.

The L-aspartic acid segment is expected to be the largest during the forecast period

The L-aspartic acid segment is expected to account for the largest market share during the forecast period, due to its extensive use in food, pharmaceutical, and cosmetic applications. Its role as a precursor in the synthesis of aspartame and other bioactive compounds enhances its commercial relevance. L-aspartic acid is also favored for its high purity and compatibility with advanced formulations. Demand is rising in nutraceuticals, where it supports energy metabolism and muscle recovery. The compound's stability and solubility make it suitable for liquid and powder formats across industries. Ongoing research into its therapeutic potential is expanding its footprint in clinical nutrition.

The pharmaceutical grade segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the pharmaceutical grade segment is predicted to witness the highest growth rate, driven by its critical role in drug synthesis and therapeutic formulations. Its use in peptide-based drugs and amino acid infusions is expanding, especially in chronic disease management. High standards of purity and bioavailability make it indispensable in clinical settings. Regulatory approvals for amino acid therapies are increasing, boosting demand across hospitals and specialty clinics. The rise of personalized medicine and targeted delivery systems is further enhancing its relevance. Manufacturers are investing in advanced purification technologies to meet stringent quality benchmarks.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, supported by strong demand from food, pharmaceutical, and cosmetic sectors. Countries like China, India, and Japan are ramping up production capacity and investing in biotech infrastructure. Government initiatives promoting amino acid-based nutrition and local manufacturing are accelerating growth. Rising health awareness and urbanization are driving consumption of low-calorie and functional products. The region's cost-effective labor and raw material availability enhance its competitiveness. Strategic collaborations between global firms and regional players are facilitating technology transfer and market penetration.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, fueled by innovation in food science, pharmaceuticals, and personal care. The U.S. and Canada are leading in R&D for amino acid applications, including novel sweeteners and therapeutic agents. Regulatory support for clean-label and health-focused products is encouraging rapid commercialization. Advanced manufacturing capabilities and robust supply chains are enabling scalability and responsiveness. Consumers are increasingly seeking plant-based and functional ingredients, boosting demand for amino acid derivatives. Strategic investments in biotech and nutraceutical startups are reshaping the competitive landscape.

Key players in the market

Some of the key players in Aspartic Acid Market include Ajinomoto Co., Inc., Tokyo Chemical Industry Co., Ltd., Evonik Industries AG, Kishida Chemical Co., Ltd., CJ CheilJedang Corp., Simson Pharma Limited, Merck KGaA, Alpha Chemika, DIC Corporation, Alpspure Lifesciences Private Limited, Iris Biotech GmbH, CDH Fine Chemicals, Bio-Techne Corporation, Zhangjiagang Huachang Pharmaceutical Co., Ltd., AnaSpec Inc.

Key Developments:

In October 2025, Merck announced that EMD Serono, the healthcare business of Merck in the U.S. and Canada, and U.S.-President Donald J. Trump's administration entered into an agreement to expand access to EMD Serono's portfolio of in vitro fertilization (IVF) therapies for the more than 10 million American women struggling to have a baby.

In March 2024, Evonik is partnering with the Chinese company Jland Biotech to market vegan collagen for cosmetic and personal care applications. To maximize the benefits from a long-term, robust partnership, Evonik has invested in Jland Biotech through its Venture Capital group. The partnership will enable Evonik to provide commercial quantities of collagen for applications in skincare such as anti-aging and hydrating creams.

Product Types Covered:

• L-Aspartic Acid
• D-Aspartic Acid
• DL-Aspartic Acid
• Other Product Types

Production Methods Covered:

• Bio-Fermentation
• Chemical Synthesis

Purity Grades Covered:

• Food Grade
• Pharmaceutical Grade
• Industrial Grade

Applications Covered:

• Food & Beverages
• Nutraceuticals & Dietary Supplements
• Pharmaceuticals
• Personal Care & Cosmetics
• Industrial Applications
• Other Applications

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Aspartic Acid Market, By Product Type

• 5.1 Introduction
• 5.2 L-Aspartic Acid
• 5.3 D-Aspartic Acid
• 5.4 DL-Aspartic Acid
• 5.5 Other Product Types

6 Global Aspartic Acid Market, By Production Method

• 6.1 Introduction
• 6.2 Bio-Fermentation
• 6.3 Chemical Synthesis

7 Global Aspartic Acid Market, By Purity Grade

• 7.1 Introduction
• 7.2 Food Grade
• 7.3 Pharmaceutical Grade
• 7.4 Industrial Grade

8 Global Aspartic Acid Market, By Application

• 8.1 Introduction
• 8.2 Food & Beverages
  • 8.2.1 Flavor Enhancers
  • 8.2.2 Protein Fortification
• 8.3 Nutraceuticals & Dietary Supplements
  • 8.3.1 Sports Nutrition
  • 8.3.2 Cognitive Health
• 8.4 Pharmaceuticals
  • 8.4.1 Drug Formulations
  • 8.4.2 Excipient Use
• 8.5 Personal Care & Cosmetics
  • 8.5.1 Anti-aging Products
  • 8.5.2 Skin Conditioning Agents
• 8.6 Industrial Applications
  • 8.6.1 Biodegradable Polymers
  • 8.6.2 Chelating Agents
• 8.7 Other Applications

9 Global Aspartic Acid Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Ajinomoto Co., Inc.
• 11.2 Tokyo Chemical Industry Co., Ltd.
• 11.3 Evonik Industries AG
• 11.4 Kishida Chemical Co., Ltd.
• 11.5 CJ CheilJedang Corp.
• 11.6 Simson Pharma Limited
• 11.7 Merck KGaA
• 11.8 Alpha Chemika
• 11.9 DIC Corporation
• 11.10 Alpspure Lifesciences Private Limited
• 11.11 Iris Biotech GmbH
• 11.12 CDH Fine Chemicals
• 11.13 Bio-Techne Corporation
• 11.14 Zhangjiagang Huachang Pharmaceutical Co., Ltd.
• 11.15 AnaSpec Inc.